EBITDA Margin % is calculated as EBITDA divided by its Revenue. Skinvisible's EBITDA for the
three
months ended in Sep. 2024 was $-0.11 Mil. Skinvisible's Revenue for the
three
months ended in Sep. 2024 was $0.01 Mil. Therefore, Skinvisible's EBITDA margin for the quarter that ended in Sep. 2024 was -2,260.00%.
Skinvisible EBITDA Margin % Historical Data
The historical data trend for Skinvisible's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Skinvisible's EBITDA Margin %
For the Household & Personal Products subindustry, Skinvisible's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Skinvisible's EBITDA Margin % Distribution in the Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Skinvisible's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Skinvisible's EBITDA Margin % falls into.
Skinvisible EBITDA Margin % Calculation
EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.
Skinvisible's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Skinvisible EBITDA Margin % Related Terms
Thank you for viewing the detailed overview of Skinvisible's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Skinvisible Inc is a pharmaceutical research and development company that has developed and patented a polymer delivery system, Invisicare and formulated over forty topical skin products, which it out-licenses globally. Invisicare is a patented polymer delivery system that enhances the delivery of active ingredients for topically applied skin care products. Its patented technology has a formula and process for combining active ingredients with a delivery system that extends the duration of time the product remains on the skin and active. The Company is also exploring new opportunities in large medical markets outside of the dermatology market such as obesity and other potential markets where a topical or transdermal solution would be a viable alternative.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SKVI has been successfully added to your 